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extracted from hospital discharge record databases from all hospitals in Lombardia (a
Northern Italy region with high density population). Main outcome measures were in-
hospital mortality and treatment modality by sex. Treatment modalities included
medical therapy alone or an invasive approach, the latter consisting of coronary
angiography alone, percutaneous coronary intervention (PCI), or coronary artery
bypass graft surgery. Multivariable logistic regression was performed to assess the
impact of female sex and of treatment modality on mortality after adjusting for age,
and comorbidities.
Results: A total of 92807 patients with STEMI, 66.4% men and 33.6% women were
enrolled. Women were older than men (mean 75.1 yrs vs 64.1 yrs, p<0.0001) and had
a higher prevalence of chronic renal failure (p<0.001). In-hospital mortality presented
a small decrease from 7.5% in 2000 to 6.3% in 2010 among men, while it remained
higher and substantially constant over time among women (16.4% in 2000, 16.2% in
2010). The use of an invasive approach increased over time in both sexes (from 55%
in 2000 to 91% in 2010 in men and from 36% in 2000 to 70% in 2010 in women). The
use of PCI increased from 32% in 2000 to 82% in 2010 in men; and from 21% in 2000
to 57% in 2010 in women. At multivariable regression, an invasive approach (odds
ratio (OR) 0.23, 95% conﬁdence interval (CI), 0.21-0.25, p<0.001) was associated
with a signiﬁcant reduction in mortality, while female sex was not a predictor of
mortality (OR 0.96, P¼0.18).
Conclusions: In-hospital mortality remains higher in women than in men, although
female sex is not a signiﬁcant predictor of mortality. Despite temporal increases in the
use of an invasive approach, women are more often treated conservatively.
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Background: The risk for recurrent ischemic events following ST-segment elevation
myocardial infarction (STEMI) gradually declines. However, current guidelines
suggest consistent therapy from presentation out to 12 months. We sought to char-
acterize the actuarial daily ischemic risk (ADIR) in the 12 months year after STEMI.
Methods: Ischemic event rates for all 3602 patients enrolled in the prospective
HORIZONS-AMI trial were categorized according to the timing of their occurrence in
three groups: Group 1: during index hospitalization, Group 2: from hospital discharge
to 30 days, and Group 3: from 30 days post hospital discharge to 1 year. Ischemic
events included: All-cause death, cardiovascular (CV) death, non-CV death, re-
infarction (MI), deﬁnite ST and the composite of CV death, MI or deﬁnite ST. The
ADIR for each event was calculated based on the actual patient days of follow-up for
each group.
Results: Highly signiﬁcant reductions in ADIR were observed as patients transitioned
from Group 1 to Groups 2 and 3 respectively (Table). The degree of ADIR reduction
approached or exceeded a full order of magnitude for all events except for non-CV
death. Accordingly, the relative risk for the composite of CV death, MI or deﬁnite ST
was 15.20 (11.39 - 20.27, p<0.0001) for Group 1 vs. Group 2, 6.31 (4.62 - 8.62,
p<0.0001) for Group 2 vs. Group 3 and 95.94 (76.06 - 121.02, p<0.0001) for Group
1 vs. Group 3.
Conclusions: Conclusions: The risk for CV death and recurrent ischemic events
following an index STEMI treated with primary PCI dramatically declines following
hospital discharge out to the ﬁrst 30 days and declines even further between day 30
and one year. These data suggest that a tailored approach to anti-ischemic protection,
with more potent agents administered in the acute and sub-acute phases and less potent
agents (with lower bleeding potential) administered after 30 days, warrants
investigation.Table. Actuarial daily ischemic risk (ADIR) in 3 successive periods after index
hospitalization for STEMI
ENDPOINT Index hospitalization Discharge to 30 Days 30 Days to 1 year
All-cause death 78/21510 (0.3626%) 22/104397 (0.0211%) 59/1220907 (0.0048%)
CV death 71 / 21510 (0.3301%) 17 / 104397 (0.0163%) 29 / 1220907 (0.0024%)
Non-CV
death
7 / 21510 (0.0325%) 5 / 104397 (0.0048%) 30 / 1220907 (0.0025%)
Re-infarction (MI) 44 / 21510 (0.2046%) 27 / 104397 (0.0259%) 84 / 1220907 (0.0069%)
Deﬁnite ST 76 / 21510 (0.3533%) 17 / 104397 (0.0163%) 0 / 1220907 (0.0000%)
CV death + MI +
Deﬁnite ST
191 / 21510 (0.8880%) 61 / 104397 (0.0584%) 113 / 1220907 (0.0093%)
Trend p-values <0.0001 for all endpoints. All pairwise p-values <0.0001, except p¼0.16 for
Group 2 vs. Group 3 non-CV death.
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Background: We sought to analyze in ST-elevation myocardial infarction (STEMI)
patients the impact of rheolytic thrombectomy (RT) in comparison to manual
thrombus aspiration (MTA) on extension of microvascular obstruction (MVO) and
infarct size (IS) as well as on 1-year left ventricular (LV) volumes and ejection fraction
(EF) by cardiac magnetic resonance imaging (MRI).
Methods: Eighty STEMI patients (6 hours from symptom onset) reperfused by
primary angioplasty with routine abciximab therapy were randomly allocated (1:1) to
a RT or MTA. MRI was performed within 10  6 days in 37 patients (19 RT, 18
MTA), and after 1 year in 19 patients (9 RT). IS and MVO were measured 15 min
after gadolinium injection with late enhancement sequences and were analyzed
quantitatively (as percentage of the left ventricular mass –gr/LV mass-) at a core
laboratory blinded to randomization.
Results: Baseline clinical characteristics were similar between the RT and MTA
groups, as well as baseline TIMI thrombus grade (4.47  0.84 vs. 4.67  0.76,
p¼0.453). After thrombectomy, in RT compared with MTA group the thrombus grade
decreased to 1.11  1.04 vs. 2.17  1.29 (P¼0.04), and after infarct artery stenting
TIMI 3 ﬂow was 100% vs. 89% (P¼0.204), and ST-elevation resolution greater than
70% at 60 minutes was 89% vs. 72% (P¼0.198), respectively. RT compared with
MTA group did not reduced signiﬁcantly myocardial IS [12.2% (6.4-22.1) vs. 19.0%
(7-28.5) , P¼0.224] as well as the extent of MVO [0.0% (0.0-0.17) vs. 0.6% (0.0-1.4),
P¼0.117], but a trend towards a lower incidence of MVO was observed (16% vs.
44%, P¼0.056). At 1-year, the IS did not change [RT 13.2% (6.4-22.1) vs. MTA
11.4% (6.5-27.8), P¼0.253] and the recovery (baseline-1-year) of LV EF was not
different in both groups (RT 1.94.5% vs. MTA 1.18.3%, P¼0.626), with
a reduction of LV volumes found only in RT group (EDV: RT -9.315 ml vs. MTA
929.8 ml, P¼.115; ESV: RT -8.515.2 ml vs. MTA 3.120.3 ml, P¼.180,
respectively).
Conclusions: In setting of STEMI, at 1-year RT in comparison to MTA did not reduce
signiﬁcantly the IS. However a more favorable change of LV volumes were found,
likely due to a more effective thrombus removal and a lower incidence of MVO by
RT.
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Background: The optimal revascularization strategy in patients with multivessel and
left main coronary artery disease (MVD, LMD) presenting with non-ST acute coro-
nary syndrome (NSTE-ACS) is undetermined.
Methods: In this multicenter, prospective registry, 4566 patients with non-ST
elevation myocardial infarction (NSTEMI), unstable angina and MVD including LMD
were enrolled. Following angiography, 3033 patients were assigned for stenting
(10.3% DES), whereas 1533 for CABG. The complete follow-up on mortality was
obtained at 3 years.
Results: In the overall population, patients assigned for PCI were younger (64.410
vs. 65.29 p¼0.03), more frequently presented with NSTEMI (32.0 vs. 14.5%;
p¼0.01), cardiogenic shock (1.5 vs. 0.7% p<0.01) history of prior PCI (13.1 vs. 5.5%;
p<0.01) and CABG (10.6 vs. 4.6%, p<0.01). The Euroscore and TIMI risk score
were slightly higher in PCI patients (5.362.3 vs. 5.162.0 and 3.871.0 vs.
3.790.9 respectively, p<0.01). Patients consigned to CABG more often presented
with triple and LMD (82.2 vs. 33.8% and 13.7 vs. 2.4%; p<0.01). Otherwise,
proximal LAD was more often stented (21.5 vs. 11.1%; p<0.01). After adjustment
929 well-matched pairs were selected. Early mortality was lower after PCI prior to
matching (2.1 vs. 3.1%; p<0.01), whereas after balancing, no difference was found
(2.5 vs. 2.8%; p¼0.62). Three year survival was in favor of PCI when compared to
surgery prior (87.5 vs. 82.8%, HR: 1.44, 95%CI: 1.2-1.7) and after matching (86.4 vs.
82.3%, HR 1.33, 95%CI:1.05-1.7 and p¼0.01). Stenting was associated withacts/POSTER/STEMI/NSTEMI/ACS B81
Variable LM STEMI
N¼63
Patient Characteristics
Age, years 64 (37-94)
Male (%) 59 (80)
BMI, kg/m2 27 (17-39)
Diabetes (%) 31 (42)
CRI Non-HD (%) 17 (23)
ESRD on HD (%) 6 (8)
Prior/Active smoker (%) 33 (45)
Dyslipidemia (%) 44 (60)
Hypertension (%) 53 (72)
Stroke (%) 9 (12)
Prior MI (%) 10 (14)
Prior PCI (%) 13 (18)
Aspirin (%) 48 (65)
Thienopyridine (%) 18 (24)
Beta Blocker (%) 19 (26)
Statin (%) 29 (39)
Creatinine, mg/dL 1.7  2.3
In hospital mortality (%) 20 (27)
ECG Characteristics
Anterior STE (%) 46 (73)
Lateral STE (%) 32 (51)
Inferior STE (%) 5 (8)
aVR STE (%) 36 (57)
Inferior STD (%) 36 (57)
Lateral STD (%) 15 (24)
Leads/ECG with STE (Mean  SD) 3.8  2.3
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score>5, TIMI risk score>4, DES and two vessel disease.
Conclusions: Based on this large registry data of patients with NSTE-ACS and MVD,
stenting was associated with lower risk of mortality at long term follow up when
compared to surgical revascularization strategy The subgroup analysis highlighted
improved outcomes with PCI in high clinical risk cohorts.
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Background: The GOTHIA CARDIOVASCULAR initiative consist of healthcare
providers of which four have a PCI department in Region Västra Götaland, Sweden.
The data was collected from SCAAR (Swedish Coronary Angiography and Angio-
plasty Registry). GP IIb/IIIa was the standard treatment during PCI in patients with
STEMI until the HORIZONS-AMI study was published 2008. After 2008 a gradual
switch to bivalirudin has occurred. The aim of this observational study was to compare
the outcome associated with treatment with glycoprotein IIb/IIIa receptor inhibitors
(GP IIb/IIIa) and bivalirudin during percutaneous coronary intervention (PCI) in
patients with ST-segment elevation myocardial infarction (STEMI).
Methods: The primary endpoint was mortality after 180 days. Missing data were
imputed using multiple imputation method. Survival was analysed with logistic
regression adjusted for age, gender, smoking status, diabetes, hypertension, hyper-
lipidaemia, prior myocardial infarction, prior PCI, prior coronary by-pass surgery, oral
platelet inhibition prior to PCI, vascular access site, severity of coronary disease,
number of stents used, mean diameter of the stent used, drug-eluting stents, cardio-
genic shock, completeness of revascularisation, and procedural success.
Results: Between 2004-2011, 3067 patients were treated with GP IIb/IIIa and 2688
patients were treated with bivalirudin during primary PCI. The adjusted odds ratio
(OR) for bivalirudin compared with GP IIb/IIIa was 1.26 (95% CI 0.98-1.61 p¼0.07).
Conclusions: In this observational study there was no statistical difference in 180 day
mortality in patients treated with bivalirudin compared with gpIIb/IIIa receptor
inhibitors. However there was a trend in favour of gpIIb/IIIa inhibitors.
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Background: Little is known regarding the various clinical predictors of myocardial
recovery in patients presenting with acute myocardial infarction (AMI) undergoing
percutaneous coronary intervention (PCI). Elevated left ventricular end-diastolic
pressure (LVEDP) is commonly observed during AMI, but few studies have examined
the prognostic value of this index. We hypothesized that lower LVEDP at presentation
would be predictive of improved myocardial recovery at 3 months.
Methods: Clinical and echocardiographic data were collected on 1,211 patients pre-
senting to a tertiary care hospital with AMI who underwent PCI between January 2007
and December 2008. Of the total group, there were 254 patients who had both
a baseline and follow up echocardiogram performed with 156 patients having
a depressed left ventricular ejection fraction (EF) of < 50% on baseline echocardio-
gram. Patients were then grouped by LVEDP < 22 or  22 mmHg based on the
median LVEDP of our study population. Myocardial recovery was deﬁned as  5%
increase in EF on follow-up echocardiogram.
Results: There were 116 patients who were included in this study, of which 53
(45.7%) had LVEDP < 22 and 63 (54.3%) had LVEDP  22 (mean LVEDP 17 vs 28
mmHg respectively, p<0.001). There was no difference in the EF between the two
groups on baseline echo (38% vs 39%, p¼0.326). However at follow up, patients in
the low LVEDP group had a higher EF (45% vs 39%, p¼0.019) and a greater
percentage of those patients showed myocardial recovery (60.4% vs 38.1%, p¼0.017).
In multivariate logistic analysis, LVEDP (OR 0.90, 95% CI:0.84-0.97), prior MI (OR
0.12, 95% CI:0.02-0.82), and TR grade (OR 4.31, 95% CI:1.25-14.90) were inde-
pendent predictors of myocardial recovery.
Conclusions: Among patients presenting with AMI undergoing primary PCI, lower
baseline LVEDP was an independent predictor of myocardial recovery. LVEDP is
a simple and routinely obtained marker that may provide prognostic information in the
setting of AMI.B82 JACC Vol 62/18/Suppl B j October 2TCT-251
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Background: ST-elevation MI (STEMI) from culprit left main (LM) coronary artery
lesions is associated with high mortality and morbidity. The electrocardiographic
(ECG) ﬁndings in this presentation are not well described.
Methods: A retrospective analysis of all of STEMI or STEMI-equivalent (ventricular
ﬁbrillation, ventricular tachycardia or resuscitated cardiac arrest) cases (n¼75) with
culprit LM lesions admitted to 5 academic hospitals in the United States and
Singapore was performed. Patients with prior LM coronary intervention, prior CABG,
or prior known LBBB were excluded. ECG and angiographic analysis were performed
in a blinded fashion.
Results: Among 75 cases, 12 presented as VT, VF, or LBBB. The ﬁndings from the
remaining 63 cases of STEMI are summarized in Table 1. The most common ECG
ﬁndings were ST elevation in the anterior leads (73%, n ¼ 46) with reciprocal ST
depressions in the inferior (57%, n¼36) and lateral (51%, n¼32) leads. There was
infrequent concomitant lateral ST (24%, n¼15) or inferior ST (8%, n¼5) elevations.
ST elevations in aVR were present in only 57% of the ECGs analyzed. The mean
number of contiguous leads with STEs is 3.8  2.3.Conclusions: The traditional pattern of anterolateral ST elevation (STE) with inferior
ST depressions (STD) in acute LM STEMI while common, is not the sole ﬁnding in
this cohort. Furthermore, STE in aVR has only a modest association with LM STEMI.
Further analysis correlating ECG ﬁndings with angiographic characteristics is
underway and will be presented.7–November 1, 2013 j TCT Abstracts/POSTER/STEMI/NSTEMI/ACS
